40 results about "Hay fever" patented technology

A cellular constituent is lysed from, produced by and / or isolated from one or more bacteria from the genus Bacteroides, and the cellular constituent, a derivative thereof, and / or one or more bacteria from the genus Bacteroides, or a modified form thereof, is employed in compositions and methods for modulating an inflammatory response.; Such methods include methods of treating, delaying the onset of, or reducing the symptoms of one or more inflammatory conditions / diseases, including corporal or gastrointestinal inflammation, for example, Irritable Bowel Syndrome, Crohn's Disease, or colitis, and / or associated diseases such diabetes, asthma, multiple sclerosis, cancer, rheumatoid arthritis, gingivitis, atopic diseases, for example, hay fever, food allergies, eczema, rhinitis, dermatitis, conjunctivitis, atopic syndrome and keratosis pelaris, ocular inflammatory disease, strokes, cardiovascular disease, depression, atherosclerosis and hypertension, and comprise administering a composition comprising one or more natural and / or modified bacteria of the genus Bacteroides, and / or a cellular constituent lysed from, produced by, or isolated from one or more natural and / or modified bacteria from the genus Bacteroides, or a derivative thereof.

Apparatus and methods are disclosed for treating allergic rhinitis (seasonal and perennial hay fever), by application of flash lamp radiation. The nasal cavity can be illuminated in a safe and effective manner, with non-coherent light from a flash-lamp or other suitable source. This illumination can be accomplished in any suitable manner, including by use of a handheld device. Such handheld embodiments may contain a power source (battery or AC), control circuitry, light source (flash-lamp or diode laser), lens (focusing or non-focusing), light filter, and / or fiber-optic for delivering light to the nasal cavity. Embodiments include using any suitable light energy, such as visible light in the red wavelengths with a power output of 1 to 10 Joules per cm2. The device can be pre-programmed to deliver a specified amount of light in a specified amount of time using multiple pulses (in the case of a flash lamp) or a continuous wave (in the case of a diode laser). In many useful embodiments, a rigid fiber-optic extends from the lens / light filter a length of 10 to 20 mm, although it can be any convenient and useful size and shape. Contact sensors can be arrayed on the device for various purposes, such as to restrict illumination to times when the fiber optic is inserted into the nasal cavity. This and / or other safety features can prevent the high-intensity light from being fired into open space, a person's eyes, and / or otherwise causing a potential vision or other hazard. Preferably, the device can be easily and comfortably inserted into a nostril. The fiber-optic can be angled (either in its own shape or by the user manipulating it to a convenient angle / position) so as to allow the user to easily grip the device and insert the fiber-optic without having to use a mirror or other aid. Light from the device can be emitted at a specified light frequency that causes a desired immunosuppressive response in the cellular system.

An air shower device which prevents allergenic substances which cause hay fever from being brought into a living space, in which a person resides or carries out an activity, by an outside body. The air shower device includes a suction unit, which takes in outside air; an air blower unit having an air blower which blows air which has been taken in, at a specific air-flow rate and a filter which cleans by removing dust, including pollen, from air which is blown; and a dust collecting unit which collects dust, including pollen, from exhaust of an air shower room which includes the air blower unit. Further, the air shower device includes an air-flow rate control unit which controls the amount of air blown by an air blower according to an amount of pollen dispersed in the outside air.

It is to provide a composition derived from lactic acid bacteria having an anti-allergic effect (an effect of suppressing allergic symptoms such as hay fever) synergistically, and a food product, pet food, etc. containing the composition. It is to prepare a composition having an anti-allergic action, containing Lactobacillus crispatus KT-11 strain, KT-23 strain, or KT-25 strain bacterial cells and viable bacteria, dead bacteria, or a processed product of bacterial cells of other lactic acid bacteria belonging to the genus Lactobacillus, genus Bifidobacterium, genus Leuconostoc, genus Enterococcus, genus Pediococcus, etc. at a biomass-converted ratio of 99:1 to 50:50, preferably 99:1 to 75:25.

Herbal compositions having anti-adipocyte fatty acid-binding protein (aP2), anti-5-lipoxygenase-activating protein (FLAP) and anti-Cysteinyl Leukotriene (CysLT)-1 receptor expression activity contain an extract of Boswellia serrata. More particularly, these herbal compositions comprise an effective amount of an enriched Boswellia extract containing from 10% to 99% by weight of 3-0-acetyl-11-keto-β-boswellic acid; and an effective amount of a second extract selected from the group consisting of an extract of Aegle marmelos, an extract of Zingiber officinale, an extract of Garcinia mangostana, and mixtures thereof. These may be used in dietary supplements or pharmaceutical formulations for controlling diseases associated with or related to inflammation. These diseases in particular include respiratory disorders such as asthma, allergic rhinitis, hay fever, type-1 hypersensitivity and mild allergies. The compositions can also be useful for skin care.

The invention provides a rose flavored vegetable ball. The vegetable ball comprises the following components in parts by weight: 10 to 15 parts of vegetables, 50 to 70 parts of chicken breast, 20 to 30 parts of chicken skin, 40 to 50 parts of ice water, 2 to 3 parts of salt, 1 to 3 parts of white granulated sugar, 2 to 5 parts of water retaining agent, 5 to 15 parts of thickener, 1 to 3 parts of flavor enhancer, and 0.005 to 0.008 part of rose flower extract. The rose flower extractive added in the product can improve the color and flavor of the vegetable ball, and has medical value while increasing color and flavor of the product, as the rose flower extractive can treat apositia of young girls, climacteric metancholia, respiratory tract infection, cough, hay fever, sinus block and the like.

The invention relates to an aspirin eugenol ester-paracetamol compound sustained-release tablet. The aspirin eugenol ester-paracetamol compound sustained-release tablet is prepared from aspirin eugenol ester, paracetamol and vitamin C. The aspirin eugenol ester-paracetamol compound sustained-release tablet has effects of effectively relieving fever, headache and upper airway symptoms caused by common cold and influenza and various symptoms caused by the hay fever, is suitable for treating cold-related symptoms, and contains active components which are released slowly.

The anti-allergy composition of the present invention comprises, as an ineffective ingredient, a wood vinegar-distilled solution. A bamboo vinegar-distilled solution obtained using a bamboo as a wood material is preferable. Also, it is preferable that the present composition does not contain benzopyrene, dibenzanthracene, and methylcholanthrene substantially. The anti-allergy composition can exhibit an anti-allergy effect by oral ingestion. In particular, it is useful for inhibiting Type I allergy such as allergic rhinitis, hay fever, allergic conjunctivitis, atopic dermatitis, allergic asthma, urticaria, food allergy, and anaphylaxis. In addition, the composition can be also applied to a skin. When a wood is subjected to smoking treatment at 130 to 170° C., dried, and then carbonized at 350 to 450° C., a smoke discharged during this carbonization treatment is condensed to obtain a crude wood vinegar, and then the crude wood vinegar is distilled at a low temperature of 50 to 60° C. under reduced pressure to obtain a wood vinegar-distilled solution.

The present invention relates to a nasal composition comprising an anti-allergic oil derived from plant; and an oil-based barrier-forming preparation. The composition may be used in preventing and / or treating allergic disorders of the nasal cavity, including seasonal allergic rhinitis (hay fever) and perennial allergic rhinitis.